Status:
COMPLETED
Effect of the PIPAC on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric Origin
Lead Sponsor:
Association Francaise de Chirurgie
Conditions:
Carcinomatosis, Peritoneal
Eligibility:
All Genders
18+ years
Brief Summary
Pressurised intraperitoneal aerosol chemotherapy is a new surgical technique, developed for the treatment of initially unresectable peritoneal carcinomatosis. The objective of this study was to compar...
Eligibility Criteria
Inclusion
- Patients 18 years or over
- Patients with adenocarcinoma-type gastric non-resectable péritonéale carcinomatosis.
- Patients without metastasis other than peritoneal.
- WHO performance status \<3
- Patients treated either with PIPAC administered in alternation with systemic chemotherapy (PIPAC\_CHEM) or by systemic chemotherapy alone (ONLY\_CHEM)
- Patient informed
Exclusion
- \- Patients opposed
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04879953
Start Date
February 1 2020
End Date
December 31 2020
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUGA
Grenoble, France